Fatigue News and Research

RSS

Cardiopulmonary limitations six months after surviving COVID-19

A recent prospective cohort study assessed the cardiopulmonary effects in patients six months after COVID-19 infection.

23 Feb 2022

Neural mechanisms of fatigue in COVID-19 convalescents

In a recent study posted to the medRxiv* preprint server, researchers characterized the mechanisms associated with neural dysregulation in post-coronavirus disease (COVID) fatigue (pCF) by evaluating individuals recovered from mild severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection.

23 Feb 2022

Mouse-adapted virus model to study persistent COVID induced lung disease

Researchers develop a mouse model to identify early biomarkers and test countermeasures needed to detect and prevent PASC.

21 Feb 2022

Poll: Most parents have limited knowledge about CBD products for children

Products containing cannabidiol (CBD), a chemical compound naturally found in marijuana and hemp, have been used in recent years to help adults manage medical issues like chronic pain and mood disorders.

21 Feb 2022

Exercise program offers psychological benefits during active surveillance for prostate cancer

In men undergoing active surveillance as an alternative to immediate treatment for prostate cancer, a supervised exercise program can reduce anxiety and fear of cancer progression, reports a study in The Journal of Urology, an Official Journal of the American Urological Association.

18 Feb 2022

Omicron outbreak in an indoor convention in New York

A recent report published by the CDC, USA, has demonstrated one of the earliest outbreaks of omicron infection in the US.

18 Feb 2022

VA researchers shine light on the dangerous mental health consequences of COVID-19

The most menacing fallout from COVID-19 often shows itself only after the initial "acute" infection passes. A team of VA researchers has been shining a light on various dangerous and enduring consequences that can arise following the initial COVID bout. These COVID complications include mental health disorders.

18 Feb 2022

Immunogenicity, efficacy, and safety of BNT162b2 or mRNA1273 fourth dose

A recent study explored the safety, immunogenicity, and VE of the SARS-CoV-2 mRNA BNT162b2 and mRNA1273 vaccines against its Omicron VOC in HCWs in Israel.

18 Feb 2022

Study characterizes brain changes in adolescents affected by juvenile fibromyalgia

Juvenile fibromyalgia is a syndrome characterized by a chronic pain affecting the whole body. It also causes fatigue as well as sleep and mood disorders.

17 Feb 2022

Frequency and function of SARS-CoV-2-specific T cells in individuals with pulmonary PASC

Researchers examined patients with pulmonary PASC of SARS-CoV-2 to determine the frequency and function of SARS-CoV-2-specific T cells in their blood.

17 Feb 2022

Study determines 115 long COVID symptoms and their associated risk factors

A new study determined which symptoms are linked with confirmed SARS-CoV-2 infection beyond 12 weeks post-infection in non-hospitalized individuals, and investigated the associated risk-factors of such symptoms.

17 Feb 2022

Risk factors for COVID-19 in older adult patients with cancer

Researchers develop a geriatric risk score to predict the risk of severe clinical outcomes in older cancer patients with COVID-19.

16 Feb 2022

UC joins nationwide trial to evaluate efficacy of repurposed drugs for mild-to-moderate COVID-19

The University of Cincinnati is joining a nationwide study to evaluate repurposed medications in the search for effective, safe treatments for mild-to-moderate COVID-19. Repurposed medications are those already approved by the U.S. Food and Drug Administration for other indications.

16 Feb 2022

Heart attack survivors may have a lower risk of Parkinson's disease

People who have had a heart attack may be slightly less likely than people in the general population to develop Parkinson's disease later in life, according to new research published today in the Journal of the American Heart Association, an open access, peer-reviewed journal of the American Heart Association.

16 Feb 2022

COVID-Somnia: the relationship between COVID-19 and insomnia

Researchers explored the links between COVID-19 and sleep disorders such as insomnia using a thorough literature review.

16 Feb 2022

Study describes sequelae presenting more than six months after COVID-19 in non-hospitalized young adults

A recent study described COVID-19 sequelae developed in non-hospitalized young adults more than six months after COVID-19 infection.

15 Feb 2022

How has telemedicine assisted COVID-19 patients?

In acknowledging the urgent need for managing outpatients, especially after hospital discharge, scientists have conducted a pilot telemonitoring program.

14 Feb 2022

Enhanced external counterpulsation therapy benefits long COVID-19 patients

In a small study of long COVID-19 patients, those with and without coronary artery disease demonstrated improvement of a variety of symptoms, including fatigue, breathing difficulties and chest discomfort, after undergoing 15-35 hours of enhanced external counterpulsation (EECP) therapy.

14 Feb 2022

Study explores the social impact of COVID-19 symptoms among female long haulers

A new study analyzed the impact of long-COVID on women long haulers with respect to various aspects of their social life.

14 Feb 2022

Researchers identify autoantibody targets in COVID-19 patients

In a new study, researchers have been investigating auto-immune responses to natural human antigens in COVID-19 patients.

14 Feb 2022

Fatigue News and Research

Cardiopulmonary limitations six months after surviving COVID-19

Neural mechanisms of fatigue in COVID-19 convalescents

Mouse-adapted virus model to study persistent COVID induced lung disease

Poll: Most parents have limited knowledge about CBD products for children

Exercise program offers psychological benefits during active surveillance for prostate cancer

Omicron outbreak in an indoor convention in New York

VA researchers shine light on the dangerous mental health consequences of COVID-19

Immunogenicity, efficacy, and safety of BNT162b2 or mRNA1273 fourth dose

Study characterizes brain changes in adolescents affected by juvenile fibromyalgia

Frequency and function of SARS-CoV-2-specific T cells in individuals with pulmonary PASC

Study determines 115 long COVID symptoms and their associated risk factors

Risk factors for COVID-19 in older adult patients with cancer

UC joins nationwide trial to evaluate efficacy of repurposed drugs for mild-to-moderate COVID-19

Heart attack survivors may have a lower risk of Parkinson's disease

COVID-Somnia: the relationship between COVID-19 and insomnia

Study describes sequelae presenting more than six months after COVID-19 in non-hospitalized young adults

How has telemedicine assisted COVID-19 patients?

Enhanced external counterpulsation therapy benefits long COVID-19 patients

Study explores the social impact of COVID-19 symptoms among female long haulers

Researchers identify autoantibody targets in COVID-19 patients

Advancing Intracellular Delivery with LumiPore®

How ELRIG Is Helping Mid-Career Scientists Navigate Leadership, Career Change and Redundancy

The role of UV-Vis in biopharma QC

Latest News